Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine, in the division of pulmonary diseases and critical care medicine, and director of the Marsico Lung Institute, explained to Gulf Today why he believes some repurposed drugs currently under consideration to treat COVID-19 patients could work.
“The lung only fails in so many different ways, and it doesn’t matter if it’s SARS CoV-2, or ifluenza, or metapneumovirus,” said Boucher. “It’s going to be therapies that are going to be useful, but are going to be incremental.”
Read the full article here.